ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AVRO AVROBIO Inc

1.19
0.00 (0.00%)
Pre Market
Last Updated: 19:00:24
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
AVROBIO Inc AVRO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 1.19 19:00:24
Open Price Low Price High Price Close Price Previous Close
1.19
more quote information »

Recent News

Date Time Source Heading
28/2/202402:50PRNUSKuehn Law Encourages CHRD, AVRO, KAMN, and CTLT Investors to..
24/2/202408:00EDGAR2Form SCHEDULE 13G - Statement of acquisition of beneficial..
06/2/202412:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202411:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202411:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202411:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202406:25PRNUSKuehn Law Encourages ICVX, CSTR, AVRO, and CALB Investors to..
31/1/202408:47EDGAR2Form 425 - Prospectuses and communications, business..
31/1/202408:07EDGAR2Form 425 - Prospectuses and communications, business..
31/1/202408:05EDGAR2Form 8-K - Current report
31/1/202401:05EDGAR2Form 425 - Prospectuses and communications, business..
31/1/202400:39EDGAR2Form 8-K - Current report
31/1/202400:00BWAVROBIO and Tectonic Therapeutic Announce Merger
10/11/202308:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/11/202307:15EDGAR2Form RW - Registration Withdrawal Request
11/8/202306:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/7/202321:13EDGAR2Form 8-K - Current report
12/7/202321:00BWAVROBIO to Explore Strategic Alternatives
04/7/202303:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202321:00BWAVROBIO Completes Sale of Cystinosis Gene Therapy Program..
22/5/202321:00BWAVROBIO Announces Agreement to Sell Cystinosis Gene Therapy..
18/5/202322:14DJNAvrobio Stock Up 16% on Positive Data for Cystinosis..
18/5/202321:00BWAVROBIO Announces Positive Data from Phase 1/2 Clinical..
11/5/202321:00BWAVROBIO Reports First Quarter 2023 Financial Results and..
01/5/202321:30BWAVROBIO Announces Leadership Transition

Your Recent History

Delayed Upgrade Clock